Association for Diagnostics & Laboratory Medicine // Advocacy & Outreach // Comment Letters // 2012 Comment Letters

2012 Comment Letters

In July 2023, we changed our name from AACC (short for the American Association for Clinical Chemistry) to the Association for Diagnostics & Laboratory Medicine (ADLM). The following page links to resources that were written prior to the rebranding and/or mentions events that took place prior to the rebranding and that contain mentions of the association’s old name.

AACC continually tracks legislative and regulatory issues of importance to clinical laboratories and the clinical laboratory profession. This is a listing of AACC 's 2012 comment letters. AACC commented on a wide range of topics to federal and state authorities.

Legislative Issues

AACC joins with the Clinical Laboratory Coalition in opposing additional cuts in laboratory payments

NOV.29.2012

AACC endorses H.R.6118, the "Taking Essential Steps for Testing Act," which would give CMS more flexibility in assessing penalties for violating the CLIA PT referral provisions

AUG.01.2012

AACC, as part of the DC Principles Coalition, opposes legislation that gives the government a greater role in determining when private sector articles are made free to the public

MAR.05.2012

AACC submits comment to CMS regarding March 7, 2012 CMS proposed rule regarding electronic health record incentive payments

MAY.07.2012

AACC provides input to the Patient-Centered Outcomes Research Institute regarding its research agenda

MAR.14.2012

AACC supports the Joint Commission's efforts to reduce inappropriate test utilization>AACC supports the Joint Commission's efforts to reduce inappropriate test utilization

JAN.20.2012

2012 Comment Letters

Legislative Issues

AACC joins with the Clinical Laboratory Coalition in opposing additional cuts in laboratory payments

AACC endorses H.R.6118, the "Taking Essential Steps for Testing Act," which would give CMS more flexibility in assessing penalties for violating the CLIA PT referral provisions

AACC supports full federal funding for the NIH National Children's Study

AACC urges legislators to oppose the elimination of funding for the Agency for Healthcare Research and Quality

AACC joins with the Clinical Laboratory Coalition in seeing the repeal of the forthcoming medical device tax

AACC opposes inclusion of LDT legislation in FDA user fee legislation

AACC supports House changes to the de novo process

AACC supports Senate changes to the de novo process

AACC supports congressional involvement regarding the FDA June 2011 RUO/IUO draft guidance

AACC joins with the Friends of AHRQ in supporting additional research funding for AHRQ

AACC, as part of the DC Principles Coalition, opposes legislation that gives the government a greater role in determining when private sector articles are made free to the public

AACC supports continued funding for the National Children's Study

AACC opposes legislation that would eliminate the Patient-Centered Outcomes Research Institute

AACC seeks answers regarding the impact of congressional legislation on patient access to laboratory developed tests

AACC and the Clinical Laboratory Coalition opposes proposed cuts in laboratory reimbursement

AACC supports congressional efforts to streamline the FDA's de novo process

Regulatory Issues

AACC writes to CMS recommendation revisions to the draft Individualized Quality Control Plan

AACC writes to the State of Massachusetts urging support for harmonization efforts

AACC writes to CMS suggesting that most molecular codes remain on the clinical laboratory fee schedule

AACC urges CMS to consider technology when determining which fee schedule to place the new molecular codes

AACC wrote to CMS opposing the placement of all molecular codes on a single fee schedule

AACC provided CMS with input regarding the payment amounts for the new 2013 CPT codes

AACC provided input to the FDA regarding the design and performance of indwelling continuous blood glucose monitors

AACC submits comment to CMS regarding March 7, 2012 CMS proposed rule regarding electronic health record incentive payments

AACC provides input to the Patient-Centered Outcomes Research Institute regarding its research agenda

AACC supports the Joint Commission's efforts to reduce inappropriate test utilization>AACC supports the Joint Commission's efforts to reduce inappropriate test utilization